Centre Hospitalier Avignon

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Lung cancer1 trial

Phase

• Phase 21 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• European Organisation for Research and Treatment of Cancer - EORTC2 trials

Running trials

• Active, not recruiting

  Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

  NCT04127110· Phase 2· European Organisation for Research and Treatment of Cancer - EORTC· Source

• Recruiting

  SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

  NCT02834884· European Organisation for Research and Treatment of Cancer - EORTC· Source

  Contact: EORTC HQ

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting